Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
105.63
-0.24 (-0.23%)
At close: Dec 5, 2025, 4:00 PM EST
106.19
+0.56 (0.53%)
After-hours: Dec 5, 2025, 7:57 PM EST
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.89 billion as of December 5, 2025. Its market cap has increased by 956.56% in one year.
Market Cap
4.89B
Enterprise Value
4.75B
1-Year Change
956.56%
Ranking
Category
Stock Price
$105.63
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.89B, an increase of 3,550.21%. That is a compound annual growth rate of 54.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 4.90B | 907.96% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |